You are here:

Home
NICE Guidance
Conditions and diseases
Cancer
Cervical cancer

Cervical cancer Products

A list of all our products on cervical cancer

Filter

Product type
1 selected

Product typeGuidanceQuality standards

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceInterventional procedures guidance

Status

StatusPublishedIn developmentAwaiting development

New and updated
1 selected

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 2 products

Sort by: Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
15 October 2025
Pembrolizumab with chemoradiation for untreated high-risk advanced cervical cancer [TSID10690]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC